BRIAN MACY: Open Payments
NPI 1235542747 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 44 payments from 12 companies in 2025. Trend: 2023 $414 · 2024 $507 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 20 | $173 |
| Calliditas Therapeutics US Inc. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Vifor Pharma, Inc. | 3 | $66 |
| Travere Therapeutics, Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Ardelyx, Inc. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Amgen Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: VELPHORO, TARPEYO, FARXIGA, Veltassa, Fabhalta, IBSRELA, Kerendia, TAVNEOS.
Industry payments across KY — which companies pay providers there.
